Balbino, Bianca <br/><br/>
The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.  [electronic resource] 

 -  The Journal of clinical investigation  03 2020 
 - 1330-1335 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI129697  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaphylaxis--chemically induced<br/>Animals<br/>Asthma--drug therapy<br/>Drug Eruptions--genetics<br/>Mice<br/>Mice, Knockout<br/>Mutation<br/>Omalizumab--adverse effects<br/>Receptors, IgG--genetics